News Sofinnova Partners raises €650m for early-stage biotechs European life sciences venture capital company Sofinnova Partners has closed its latest fund, Sofinnova Capital XI, raising €650 million.
News Joy as retinal implant restores sight in geographic atrophy A wireless retinal implant already filed for approval has been shown to restore vision in patients with eye disease geographic atrophy.
News UK and US agencies team up for medtech, AI regulation The regulatory authorities in the UK and US have agreed to work more closely together on the regulation of medical technologies and AI.
News New £1.2bn science park opens in Oxford A new £1.2 billion science and technology park was formally opened today in Oxford, in a welcome boost to the UK's life sciences sector.
News Biolinq bags FDA okay for autonomous glucose sensor Biolinq gets an FDA green light for its autonomous, needle-free continuous glucose monitor, plus a roundup of other medtech developments.
News GlucoModicum's non-invasive CGM nears first filing Finland's GlucoModicum thinks it is in the lead in the race to bring a non-invasive continuous glucose monitor (CGM) to market.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.